Status:
COMPLETED
COVID-19 and Pregnancy: Placental and Immunological Impacts
Lead Sponsor:
Hopital Foch
Conditions:
Covid19
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The aim of this study is to compare placental pathologies in patients with COVID 19 infection at the time of childbirth or a history of COVID 19 during pregnancy versus control patients
Detailed Description
The second wave of COVID 19 is currently sweeping through Europe. If the first wave brought reassuring elements on the risk of maternal-fetal transmission, it nevertheless counted an increase in sever...
Eligibility Criteria
Inclusion
- Patient pregnant for more than 20 weeks with amenorrhea
- Having completed a COVID 19 PCR within 72 hours
- Admitted to the birthing room at Foch hospital for her delivery
Exclusion
- Minor (age \<18 years, on inclusion)
- Diabetes with and without insulin (only for the control group)
- High blood pressure (only for the control group),
- Preeclampsia (only for the control group)
- Infection during pregnancy: HIV, toxoplasmosis, rubella, CMV, syphilis.
- PCR Influenza A or B positive, proven by nasopharyngeal swab in the week preceding childbirth
Key Trial Info
Start Date :
December 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 8 2021
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT04726111
Start Date
December 30 2020
End Date
September 8 2021
Last Update
June 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Foch
Suresnes, France, 92150